Park Square Executive Search is pleased to announce the placement of Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth...

So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!

Park Square Executive Search has placed Pete Ligotti as Chief Commercial Officer at Elutia, a pioneer in drug-eluting biomatrix...

Park Square has placed Aarif Khakoo, MD, MBA as Chief Scientific Officer at Generate:Biomedicines.

Park Square is excited to announce two placements at Rune Labs: Amy Gordon Franzen has been named Chief Executive Officer, and Adam...

Park Square has placed Thong Le and Paul Sekhri as members of the Board of Directors at Deep Genomics. 

Park Square has placed Daniel Elgort, Ph.D. as Chief Data & Analytics Officer at Character Biosciences.

Park Square has placed Casey Lippmeier, Ph.D. as Chief Technology Officer at Checkerspot. 

Park Square has placed David Woodhouse as Chief Executive Officer at Nuvig Therapeutics.

Park Square has placed Monica Gostissa, Ph.D. as Chief Scientific Officer at Matrisome Bio. Matrisome Bio is the world leader in...

Park Square has placed Derek Hicks as Chief Executive Officer at Rezo Therapeutics.

Park Square has placed Dan Brounstein as Chief Executive Officer at Avivomed.

Park Square has placed Loïc Vincent, Ph.D. as Chief Scientific Officer at Korro Bio.

Park Square is pleased to announce the placement of Jamie Lewis as Chief Commercial Officer at Inflammatix. Inflammatix is a pioneering...

Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences. 

Park Square is pleased to announce the placement of Julia Tran at Xaira Therapeutics, where she will lead the People and Culture...